Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 31 (KLHL31) is a muscle-specific member of the Kelch protein superfamily, functioning as a substrate adaptor for Cullin 3 (CUL3)-mediated E3 ubiquitin ligase complexes involved in ubiquitin-proteasome dependent degradation of proteins[1][2][4]. KLHL31 localizes to the Z-disc of sarcomeres in skeletal muscle and is critical for maintaining muscle fiber integrity, regulating protein turnover, and muscle growth[1][2]. KLHL31 interacts directly with CUL3 to mediate polyubiquitination (K48 linkage) of substrate proteins such as Filamin-C (FlnC), targeting them for degradation[1][2]. In mouse models, deletion of KLHL31 results in postnatal muscle growth defects, centronuclear myopathy, sarcomeric and sarcotubular disorganization, and protein accumulation within muscle fibers[1][2][4]. While genes of the KLHL family have been implicated in diverse cellular processes like cytoskeletal organization and transcriptional regulation, KLHL31 is predominantly implicated in skeletal muscle maintenance and congenital myopathies[1][2][3]. There are no approved drugs or known clinical interventions targeting KLHL31. Note: KLHL31 is *not* currently a recognized therapeutic target (such as an enzyme, receptor, transporter, or direct disease mediator), but is of research interest—particularly in muscle biology and the genetics of congenital myopathies[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 31 (KLHL31).